StockData

Bon Natural Life Ltd (BON) stock

BONNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends September 30
Financials through fiscal 2025, year ended Sep 30, 2025Last filing: 20-F on Jan 23, 2026Score 0/30
$1.04−0.03 (-2.80%)

Close on Nov 18, 2026Market cap $8.45MP/E –Yield –

Bon Natural Life operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

For fiscal 2025 it was -$1.62M, down 186.6% from the year before. The highest annual figure on record is $6.60M in fiscal 2022.

Annual operating income

PeriodPeriod endValueChange
FY2025Sep 30, 2025-$1.62M-186.6%
FY2024Sep 30, 2024$1.87M-68.4%
FY2023Sep 30, 2023$5.94M-10.0%
FY2022Sep 30, 2022$6.60M+22.2%
FY2021Sep 30, 2021$5.40M+55.7%
FY2020Sep 30, 2020$3.47M+9.2%
FY2019Sep 30, 2019$3.18M–

More Bon Natural Life figures

See a number that looks wrong?